VIEW PDF 15 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new U.S. Patents. The new patents include 10,085,689 (Device and method for monitoring and assessment of movement disorder symptoms) issued…
Blog Archives
Great Lakes NeuroTechnologies Receives Two New NIH SBIR Grant Awards
VIEW PDF 1 OCT 2018: Independence, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it has been awarded two new Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH), which will provide nearly $2 Million…
Great Lakes NeuroTechnologies Wins Patent on Using Cell Phones and Smart Watches to Help Treat Parkinson’s Disease
VIEW PDF 08 DEC 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) received another Notice of Allowance for a new patent covering the use of cell phones and watches to analyze movement disorders such as Parkinson’s disease. The new…
Great Lakes NeuroTechnologies Expands Patent Portfolio
VIEW PDF 12 SEPT 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) expanded its large patent portfolio covering deep brain stimulation (DBS) tuning to 11 issued patents (and 20 currently pending applications) when it was recently awarded Patent 9,717,920…
Great Lakes NeuroTechnologies Receives Two Deep Brain Stimulation Programming Patents
VIEW PDF 21 FEB 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has recently received two Deep Brain Stimulation (DBS) tuning patents. DBS is used on patients with Parkinson’s disease and other movement disorders to help mitigate their symptoms. …
Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent
VIEW PDF 11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to…
Great Lakes NeuroTech to collaborate with UCB on Wearables and Data Visualization Tools to help improve patient experiences for people with Parkinson’s Disease
VIEW PDF 26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the…
WEARABLE TECHNOLOGY IN PARKINSON’S DISEASE DEMONSTRATES INCREASED REFERRAL RATE FOR ADVANCED THERAPY
VIEW PDF 20 JUL 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has completed and published a clinical study validating that remote monitoring with wearable, objective measures can lead to an increased referral rate for advanced therapies in Parkinson’s…
GREAT LAKES NEUROTECH VALIDATION STUDIES ON WEARABLE TECH FOR PARKINSON’S TO BE HIGHLIGHTED AT MOVEMENT DISORDER SOCIETY ANNUAL MEETING IN BERLIN
VIEW PDF 15 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that three scientific research studies validating Kinesia wearable tech for Parkinson’s disease applications will be highlighted at the 20th International Congress of Parkinson’s Disease and…
GREAT LAKES NEUROTECH ISSUED 4 PATENTS COVERING WEARABLES FOR MEASURING SYMPTOMS, ADJUSTING THERAPIES, AND DATABASE LEARNING IN PARKINSON’S DISEASE
VIEW PDF 10 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received four issued patents from the U.S. Patent Office, focused on wearable technology for Parkinson’s disease diagnostics and treatment. The issued intellectual property…